• Product type

    Asset class

    Investment focus

  • Insights
  • How to buy

  • We introduce ourselves

    Fraud prevention""

    • ESG Developed World All Cap Equity Index Fund - Institutional Plus GBP Acc (VGSGAIP)

    Available in other share classes
    Related Documents
    NAV Price ()
    —
    Number of stocks
    —
    —
    Risk Indicator
    —
    ""

    Start a savings plan or make a one-off investment

    Invest now with an online broker

    Learn more

    About this fund

    Fund objectives

    • The Fund employs a passive management – or indexing – investment approach and seeks to track the performance of the FTSE Developed All Cap Choice Index (the “Index”).
    • The Index is a market-capitalisation-weighted index composed of large-, mid-, and small-cap stocks of companies located in developed markets around the world. Market-capitalisation is the value of a company's outstanding shares in the market and shows the size of a company.
    • The Index is constructed from the FTSE Developed All Cap Index which is then screened for certain environmental, social and governance (i.e. controversy-related) criteria.
    • Through the screening out of stocks of companies from its portfolio based on the potentially detrimental impact of their conduct or products on society and / or the environment, the Fund promotes certain environmental characteristics and social characteristics relating to social norms and standards.
    • The Fund attempts to:1. Track the performance of Index by investing in all, or substantially all, of the constituent securities of the Index in the same proportion as the Index. Where not practicable to fully replicate, the Fund will use a sampling process. 2. Remain fully invested except in extraordinary market, political or similar conditions where the Fund may temporarily depart from this investment policy to avoid losses.
    • The Index methodology excludes stocks of companies that the sponsor of the Index determines (a) to be engaged or involved in specific activities of the supply chain for, and / or (b) derive revenue (above a threshold specified by the Index provider) from, certain activities relating to the following activities: (a) Vice Products (i.e., adult entertainment, alcohol, gambling, tobacco, cannabis); (b) Non-Renewable Energy (i.e., nuclear power, and fossil fuels (including power generation from oil, gas, and thermal coal which includes: (i) companies that have greater than 50% ownership of companies that own proved or probable reserves in coal, oil or gas, (ii) oil and gas production and supporting services, (iii) coal extraction, production and supporting services, (iv) oil and gas and thermal coal power generation, (v) extraction of arctic oil and gas, and (vi) extraction of oil sands)); and (c) Weapons (chemical & biological weapons, cluster munitions, anti-personnel landmines, nuclear weapons, civilian firearms, and conventional military weapons). The Index provider defines what constitutes “involvement” in each activity. This may be based on percentage of revenue or any connection to a restricted activity regardless of the amount of revenue received, and will relate to specific parts of the supply chain.
    • Company product and conduct involvement is monitored on a yearly basis by the Index provider and as new data is made available to the Index provider.
    • For the full investment strategy please review the prospectus.

    Fund facts

    Share class inception
    02 Sep 2014
    Minimum initial investment
    £100,000,000.00
    Investment structure
    Irish UCITS
    Share Class Assets'
    Total Assets
    Strategy
    Index
    Asset Class
    Equity
    Domicile
    Ireland
    Dividend schedule
    —
    Legal entity
    Vanguard Investment Series PLC
    Tax status
    Germany,United Kingdom reporting
    Benchmark
    FTSE Developed All Cap Choice Index

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Performance

    Risk and Volatility

    As at 31 Mar 2026

    Beta
    R²
    Annualized Tracking Error
    1 year
    3 years
    5 years

    Please note Beta and R-squared data will only display for funds with 3 full years of history.

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Portfolio data

    Characteristics
    FundamentalsFundBenchmarkAs at
    Number of stocks 3,554 4,406 31 Mar 2026
    Median market capital 121.1 B 121.7 B 31 Mar 2026
    22.2 x 22.1 x 31 Mar 2026
    3.4 x 3.3 x 31 Mar 2026
    19.6% 19.6% 31 Mar 2026
    21.4% 21.3% 31 Mar 2026
    Portfolio turnover rate -24.8% — 31 Mar 2026

    Market allocation

    As at 31 Mar 2026

    CountryRegionFundBenchmarkVariance +/-
    United States of AmericaNorth America 71.11% 71.22% -0.11%
    JapanPacific 6.44% 6.44% 0.00%
    United KingdomEurope 2.79% 2.66% 0.13%
    CanadaNorth America 2.78% 2.78% 0.00%
    SwitzerlandEurope 2.47% 2.48% -0.01%
    South KoreaPacific 2.19% 2.19% 0.00%
    GermanyEurope 2.04% 2.03% 0.01%
    AustraliaPacific 1.78% 1.78% 0.00%
    NetherlandsEurope 1.38% 1.38% 0.00%
    FranceEurope 1.38% 1.38% 0.00%
    SwedenEurope 1.02% 1.02% 0.00%
    SpainEurope 0.79% 0.80% -0.01%
    ItalyEurope 0.73% 0.74% -0.01%
    Hong KongPacific 0.56% 0.56% 0.00%
    DenmarkEurope 0.50% 0.50% 0.00%

    Holdings details

    As at 31 Mar 2026

    Holding name% of market valueSectorRegionMarket valueShares
    NVIDIA Corp 5.72362% Technology US £369,560,750.40 2,119,041
    Apple Inc 5.12761% Technology US £331,077,937.65 1,304,535
    Microsoft Corp 3.84856% Technology US £248,492,159.64 671,292
    Amazon.com Inc 2.80087% Consumer Discretionary US £180,845,422.94 868,322
    Alphabet Inc 2.35664% Technology US £152,162,949.12 529,152
    Broadcom Inc 2.00428% Technology US £129,411,702.18 418,118
    Alphabet Inc 1.89021% Technology US £122,046,595.02 425,457
    Meta Platforms Inc 1.75073% Technology US £113,040,301.14 197,578
    Tesla Inc 1.47050% Consumer Discretionary US £94,946,808.75 255,405
    Eli Lilly & Co 1.03294% Health Care US £66,694,362.24 72,512

    Total allocation percentages shown in the holdings details or the spreadsheet may not equal 100%, due to rounding or omission of cash and/or derivative instruments.

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Weighted equity exposures exclude any temporary cash investments and equity index derivatives.

    Prices and distribution

    Prices

    NAV Price (GBP)
    £365.65
    Change
    +£2.350.65%
    At closure 16 Apr 2026
    NAV 52-week high
    £365.65
    At closure 17 Apr 2026
    NAV 52-week low
    £269.88
    At closure 17 Apr 2026
    NAV 52-week difference
    £95.77
    Change
    +26.19%
    At closure 17 Apr 2026
    Historical Prices

    -

    Inception date

    02 Sep 2014

    Date NAV (GBP)
    16 Apr 2026 £365.6488
    15 Apr 2026 £363.3036
    14 Apr 2026 £359.8680
    13 Apr 2026 £357.3626
    10 Apr 2026 £354.6552
    09 Apr 2026 £355.1551
    08 Apr 2026 £353.4833
    07 Apr 2026 £346.6876
    06 Apr 2026 £346.9797
    02 Apr 2026 £344.9132

    Distribution history

    Distribution frequency

    —

    Historical performance 31 Mar 2026

    1.14%

    All dividends are reinvested for the "Accumulation" shares.

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Purchase information

    Currency

    Base currency: GBP

    Fund codes

    • Bloomberg: VGSGAIP
    • Citi: KQ5E
    • ISIN: IE00BPT2BN12
    • MEX ID: VIAAGV
    • SEDOL: BPT2BN1

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    SEDOL and SEDOL Masterfile® are registered trademarks of the London Stock Exchange Group PLC. SEDOL data was extracted from the London Stock Exchange SEDOL Masterfile®.